stock split HTG Molecular Completes 1-For-15 Reverse Stock Split The company stock will now trade on a split-adjusted basis on the Nasdaq after reducing its number of shares from 200 million to 26.7 million. Biocept Completes Reverse Stock Split, Adds New Managed Care Contract for Liquid Biopsy Tests The company's stock will now trade on a split-adjusted basis on the Nasdaq after authorization for the split was approved by stockholders. Interpace Biosciences to Sell $20M in Preferred Stock, Plans Reverse Stock Split The company recently changed its name from Interpace Diagnostics as it expands its focus to include drug discovery and development services. OpGen Plans Reverse Stock Split The disclosure comes less than a week after the company said that it was out of compliance with the Nasdaq's minimum shareholder equity requirement. Precipio to Effect 1-for-15 Reverse Stock Split The cancer diagnostics developer said it was undertaking the reverse stock split in order to meet the Nasdaq's $1 minimum bid price requirement. Jan 17, 2018 OpGen to Execute 1-for-25 Reverse Stock Split Dec 27, 2017 OpGen to Meet With Nasdaq Panel to Stave Off Delisting Jun 2, 2017 Pressure Biosciences Plans Reverse Stock Split Mar 16, 2017 Rosetta Genomics Announces Reverse Stock Split Dec 28, 2016 Interpace Effecting a 1-for-10 Reverse Stock Split Dec 23, 2016 Great Basin to Effect 1-for-300 Reverse Stock Split Nov 28, 2016 WaferGen Enacts Reverse Stock Split Oct 11, 2016 Roka Bioscience Plans 1-for-10 Reverse Stock Split Sep 15, 2016 Great Basin Scientific Plans Reverse Stock Split Aug 15, 2016 Qiagen Announces $250M Synthetic Share Repurchase Program Jan 27, 2016 CombiMatrix Initiates 1-for-15 Reverse Stock Split Dec 11, 2015 In Brief This Week: Roche; Danaher; Transgenomic; and More Dec 9, 2015 Great Basin Shareholders Approve Reverse Stock Split Oct 8, 2015 MetaStat Effects One-for-15 Reverse Stock Split Jul 9, 2015 BG Medicine Effects One-for-Four Reverse Stock Split Apr 7, 2015 Nanosphere to Effect a 20-to-1 Reverse Stock Split Mar 4, 2015 Nanosphere Proposes Share Number Increase, Reverse Stock Split Jun 30, 2014 Seeking Nasdaq Listing, WaferGen Effects One-for-10 Reverse Stock Split Jan 16, 2014 Transgenomic Eyes Nasdaq Listing, Splits Stock; Partners with Horizon Discovery on Standards Aug 28, 2013 Wafergen Effects Reverse Stock Split, Targets $17.3M in Private Placement Load More Breaking News In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.